FDA OKs First Cancer Drug by Genetic Type, Not Organ of Origin

WEDNESDAY, May 24, 2017 — Many new cancer drugs target genetic “biomarkers” that are specific to tumors — wherever in the body they may appear.
So on Tuesday, the U.S. Food and Drug Administration announced that, for the first time, it had…
Source: Topamax